Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Gray

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2009
Prediction of outcome following hypoxia/ischaemia in the human infant using cerebral impedanceB E Lingwood, G N Healy, Z Kecskes, et al.
Journal of Paediatrics and Child Health|May 11, 1999
The influence of growth on development outcome in extremely low birthweight infants at 2 years of ageJ M Connors, M J O'Callaghan, Y R Burns, et al.
Journal of Paediatrics and Child Health|April 1, 1996
Prevalence and aetiology of neurological impairment in extremely low birthweight infantsJ Waugh, M J O'Callaghan, D I Tudehope, et al.
Developmental Medicine and Child Neurology|November 1, 1993
Perinatal hypoxic-ischaemic brain injury: prediction of outcomeP H Gray, D I Tudehope, J P Masel, et al.
Early Human Development|October 7, 1997
Characteristics at four months follow-up of infants born small for gestational age: a controlled studyD G Newman, M J O'Callaghan, J M Harvey, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1997
Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm deliveryP H Gray, T M Hurley, Y M Rogers, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 23, 2004
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trialP Steer, V Flenady, A Shearman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 6, 2009
Prediction of outcome following hypoxia/ischaemia in the human infant using cerebral impedanceB E Lingwood, G N Healy, Z Kecskes, et al.
Journal of Paediatrics and Child Health|May 11, 1999
The influence of growth on development outcome in extremely low birthweight infants at 2 years of ageJ M Connors, M J O'Callaghan, Y R Burns, et al.
Journal of Paediatrics and Child Health|April 1, 1996
Prevalence and aetiology of neurological impairment in extremely low birthweight infantsJ Waugh, M J O'Callaghan, D I Tudehope, et al.
Developmental Medicine and Child Neurology|November 1, 1993
Perinatal hypoxic-ischaemic brain injury: prediction of outcomeP H Gray, D I Tudehope, J P Masel, et al.
Early Human Development|October 7, 1997
Characteristics at four months follow-up of infants born small for gestational age: a controlled studyD G Newman, M J O'Callaghan, J M Harvey, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1997
Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm deliveryP H Gray, T M Hurley, Y M Rogers, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 23, 2004
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trialP Steer, V Flenady, A Shearman, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1999
Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV diseaseH C Meissner, J R Groothuis, W J Rodriguez, et al.
Pageof 6